During this introductory session, delegates will gain a complete guide to the status and impact of the latest guidelines for combination products.
Why should you Attend:
This webinar will examine the regulatory requirements for drug device combinations in the case of a drug and a device and for integral products.This webinar will cover the basic requirements of how to stay compliant.
Areas Covered in the Session:
Managing third parties and document control
Vigilance and adverse event reporting
Who Will Benefit:
Salma Michor , PhD, MSc, MBA, CMgr, RAC is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously, Michor worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH.
Compliance4All DBA NetZealous,
Full Details & Registration Link: http://www.compliance4all.com/control/w_product/~product_id=501314LIVE?channel=ticketprinting_Jul_2017_SEO